9-May-2024
No headlines found.
No press releases found.
No news found.
BTAL's objective is to provide a consistent negative beta exposure to the U.S. equity market. BTAL strives to achieve this objective by investing primarily in long positions in low beta U.S. equities and short positions in high beta U.S. equities on a dollar neutral basis, within sectors. The investment objective and Principal Investment Strategies of the AGFiQ U.S. Market Neutral Anti-Beta Fund were changed on February 14, 2022. It dopped Dow Jones U.S. Thematic Market Neutral Low Beta Index, to become actively managed. On January 27, 2023 BTAL's name changed from AGFiQ U.S. Market Neutral Anti-Beta Fund to AGF U.S. Market Neutral Anti-Beta Fund.
Agf U.S. Market Neutral Anti-Beta trades on the ARCA stock market under the symbol BTAL.
As of May 9, 2024, BTAL stock price declined to $18.88 with 136,255 million shares trading.
BTAL has a beta of -0.85, meaning it tends to be less sensitive to market movements. BTAL has a correlation of 0.37 to the broad based SPY ETF.
BTAL has a market cap of $269.04 million. This is considered a Small Cap stock.
In the last 3 years, BTAL stock traded as high as $22.04 and as low as $16.15.
BTAL has underperformed the market in the last year with a price return of -4.3% while the SPY ETF gained +28.2%. BTAL has also underperformed the stock market ETF in the last 3 month and 2 week periods returning +3.9% and -0.8%, respectively, while the SPY returned +4.1% and +3.3%, respectively.
BTAL support price is $18.76 and resistance is $19.24 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BTAL stock will trade within this expected range on the day.